Privia Health Group Inc Dossier - Source-backed chat

Privia Health Group Inc

PRVANASDAQ

SectorHealth Care

IndustryHealth Information Services

Beta (adjusted)0.92

Intrinsic Value $28.81median of 6 methods · middle span $23-$42based on filings through 30 Jun 2026

Market Price $20.03Price as of 1 Oct 2026

UndervaluedIntrinsic value is 44% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $2.6B

Enterprise Value $2.1B

Shares Outstanding 132.1M diluted

Moat Rating None

Next Earnings Date5 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Privia Health Group, Inc. (PRVA) represents a highly compelling, asset-light physician enablement platform that is uniquely positioned to benefit from the secular transition toward value-based care (VBC). By partnering with independent medical groups and health systems under a single-TIN model, Privia scales its provider network with minimal capital expenditure, driving high visibility into recurring revenue streams and robust free cash flow conversion. Despite near-term market volatility and quarterly EPS fluctuations, the company's strong balance sheet (characterized by zero debt and a substantial cash position) and consistent double-digit growth in practice collections and adjusted EBITDA support a highly favorable risk-reward profile.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets18 analysts · as of 18 Aug 2026

Low · most bearish analyst$24.00

Mean target$31.67

High · most bullish analyst$40.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$24.0020%

Intensifying competition from well-capitalized incumbents (e.g., Optum, VillageMD) slows provider recruitment and increases acquisition costs. Persistent regulatory headwinds in Medicare Advantage risk adjustment and Medicaid reimbursement compress care margins, while elevated stock-based compensation continues to weigh on GAAP net income, limiting multiple expansion.

Base CaseCentral scenario

$31.6750%

Matches the consensus mean

Privia successfully executes on its 2026 guidance, growing implemented providers to approximately 5,900-6,000 and practice collections to $3.65-$3.75 billion. Adjusted EBITDA grows by 16-23% year-over-year to approximately $150 million, with an 80% conversion rate to free cash flow. The valuation is supported by a solid 17% EBITDA CAGR through 2027, justifying a price target aligned with historical multiples.

Bull CaseUpside scenario

$36.0030%

Accelerated onboarding of independent providers in newly entered regions (such as the Midwest and Pacific Northwest) drives same-store and new-market growth above expectations. Rapid transition of attributed lives into high-margin risk-bearing arrangements, combined with successful deployment of clinical AI tools, expands operating margins and drives adjusted EBITDA growth toward the high end of guidance ($155 million+), resulting in multiple expansion.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Highly scalable, capital-light business model that partners with independent physicians without requiring clinic ownership.
Strong balance sheet with over $410 million in net cash and zero debt, providing significant financial flexibility.
Exceptional free cash flow generation, with a target conversion rate of approximately 80% of adjusted EBITDA.
Robust secular tailwinds from the ongoing transition of the U.S. healthcare system toward value-based care models.

Key Investment Risks

Dependence on individual physician recruitment and retention to sustain organic growth in existing and new markets.
Exposure to regulatory changes and reimbursement rate pressures within Medicare Advantage and Medicaid programs.
GAAP profitability compression driven by high non-cash stock-based compensation expenses.

Thesis Invalidation Triggers

A significant decline in gross provider retention rates below historical high levels.
A structural shift in CMS policy that materially reduces the financial incentives for value-based care participation.
Failure to convert at least 70% of adjusted EBITDA into free cash flow over consecutive fiscal periods.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.